Form 4 for BSX Boston Scientific
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0001225208-24-002042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-14 | 2024-02-12 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -6,000 | 184.4K | -3% | $0 |
| DI | 2024-02-14 | 2024-02-12 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | +550 | 4,894 | +13% | $0 |
| DM | 2024-02-14 | 2024-02-12 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | A - Grant | $0.00 | +50.4K | 36.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-12 | G | D | 6,000 | $0.00 | 184,354 | D By Child | — | — | |
| 2 | Common | Common Stock | 2024-02-12 | G | A | 550 | $0.00 | 4,894 | I | — | — | (F1) The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose. |
| 3 | Derivative | Restricted Stock Units | 2024-02-12 | A | A | 13,848 | $0.00 | 13,848 | D | — · — to 2028-02-12 | 13,848 Common Stock | (F3) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F4) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-02-12 | A | A | 36,509 | $0.00 | 36,509 | D | $64.99 · — to 2034-02-12 | 36,509 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. |